Navigation Links
Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
Date:6/30/2009

LONDON, June 30 /PRNewswire/ -- Two-dimensional electrophoresis (2DE) is the most cost-effective protein profiling technology and is the only technology in which the constituents of a protein sample can be entirely visualised in a single gel. However, current technical limitations will need to be effectively tackled for these advantages to be leveraged and market growth to be maximised.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com), European 2-Dimensional Electrophoresis Market, finds that the market earned revenues of about $130.0 million in 2008 and estimates this to reach nearly $159.2 million in 2015. The following segments are covered in the research: two-dimensional gel electrophoresis, liquid chromatography and mass spectrometry.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brief brochure will be sent to you by e-mail.

"The global recession is bound to affect government research spending which is like oxygen to academic researchers," remarks Frost & Sullivan Research Analyst Rasika Ramachandran. "The current economic situation is therefore a blessing in disguise for the 2DE industry as researchers will be on the prowl for cheaper technologies in a cash-crunched climate. Participants in the market should capitalise on the prevailing situation to improve their revenues."

The European 2DE market is projected to grow at a better rate in the near term, as academic researchers - the main consumers of these products - are likely to invest more in cheaper alternatives for protein expression studies, such as 2DE.

Sample preparation solutions are never 'one-size-fits-all' and can vary dramatically from one kind of sample to the other. They can also differ depending on which part of the proteome the researcher wants to study.

Companies therefore find it very difficult to come out with sample preparation kits that will effectively address the varied needs of the market. A large number of products are required to address this market, but each of these products will enjoy only a limited response due to the differing needs of customers.

"Sample preparation is a major challenge that the industry needs to overcome," states Ramachandran. "It affects both the reproducibility and the resolution of the 2DE experiment which, in turn, influences the end results."

It is advisable for market participants to focus on determining the kinds of samples that are the most widely studied in the market. Following this, a feasibility analysis to check the financial viability of developing a sample preparation kit for such samples should be conducted. This can help market participants to more effectively fulfill varied sample requirements.

However, the industry has to consider that customers need to be provided strong technical support. This aspect, therefore, also has to be factored into any feasibility study related to the development of sample preparation kits.

"Industry participants need to address the sample preparation market in a more consolidated manner, whereby every sample preparation kit developed by each company should effectively address a unique niche," advises Ramachandran. "This strategy will ensure that participants do not cannibalise each other's customer base."

European 2-Dimensional Electrophoresis Market is part of the Drug Discovery & Clinical Diagnostics Growth Partnership Services programme, which also includes research in the following markets: Opportunities for the European Mass Spectrometry Market in Basic Research Applications and European Protein Purification Markets. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

European 2-Dimensional Electrophoresis Market

M2AF

    Contact:
    Katja Feick
    Corporate Communications - Europe
    P: +49 (0) 69 7703343
    E: katja.feick@frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedPro Imaging Adds Wayman and Sanford to Growing Sales Team
2. Forsyth Medical Center's Derrick L. Davis Forsyth Regional Cancer Center to Take Part in Research Trial for Patients with Fast-Growing Brain Tumors
3. A Growing Number of Brits Cross the Atlantic for Donor Egg IVF Treatment at Shady Grove Fertility Center
4. GeoFitness, Inc. is Now GeoMotion Group, an Innovative and Fast Growing Learning and Fitness Company for All Ages
5. Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry
6. Ground-breaking study to cap the growing trend of type 2 diabetes in overweight adolescents
7. Avantpage Translations Releases White Paper on Capturing The Fastest Growing Healthcare Market In America
8. Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making
9. New survey highlights growing concern about risk of infection in cancer patients
10. New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance
11. Carefxs Newest White Paper Illuminates Healthcare CIOs Growing Role in Operations, Strategic Thinking and IT Project Decision Making
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... Illustrate, Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time ... Rights (OCR) HIPAA audit and properly satisfy the law. , Thanks to the ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... and social campaign, “Humans With Vaginas.” The goal is to ignite conversation via ... non-toxic personal care products. The brand has declared September “Humans with Vaginas” month, ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Trials I Face to Receive ... he emotionally pens his aspirations and goals to better one’s life through God. “The ... Green, while searching in all the wrong places, found a love for writing. Green ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm CORDA Investment ... 8, and Monday, September 11, off work and rolled up their sleeves to help ... to local homes to start the process of rebuilding. , CORDA founder Bonner C. ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
Breaking Medicine Technology: